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1. Introduction 
Hyperthermia is one of many techniques used in oncology. It uses the physical methods to 
heat certain organ or tissue delivering an adequate temperature in an appropriate period of 
time (thermal dose), to the entire tumor volume for achieving optimal therapeutic results. 
Thermal dose has been identified as one of the most important factors which, influences the 
efficacy of hyperthermia [Perez and Sapareto (1984)]. Although there are definite 
prescriptions for temperature (generally 43	℃) and time (usually 60	݉݅݊), variations in the 
temperature and time of delivery are frequent throughout the treatment sessions [Perez and 
Sapareto (1984), Jordan et al. (1999), Jordan et al. (2001), Overgaard et al. (2009)]. 
The effectiveness of hyperthermia treatment is related to the temperature achieved during 
the treatment. An ideal hyperthermia treatment should selectively destroy the tumor cells 
without damaging the surrounding healthy tissue. [Andrä et al. (1999), Lagendijk (2000), 
Moroz et al. (2002), Maenosono and Saita (2006), Lin and Liu (2009)]. Therefore, the ability to 
predict the temperature distribution inside as well as outside the target region as a function 
of the exposure time, possesses a high degree of importance. 
In the past fifteen years, MFH has drawn greater attention due to the potential advantages 
for cancer hyperthermia therapy. In MFH, a nanofluid containing the MNPs is injected 
directly into the tumor. An alternating magnetic field is then applied to the target region, 
and then MNPs generate heat according to Néel relaxation and Brownian rotation losses as 
localized heat sources [Jordan et al. (1999), Jordan et al. (2001), Thiesen and Jordan (2008)]. 
The heat generated increases the temperature of the tumor. In general, the cancerous cells 
possess a higher chance to die when the temperature is above 43	℃ whereas healthy cells 
will be safe at this temperature [Andrä et al. (1999), Moroz et al. (2002)]. 
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Two techniques are currently used to deliver the MNPs to the tumor. The first is to deliver 
particles to the tumor vasculature [Matsuki and Yanada (1994)] through its supplying 
artery; however, this method is not effective for poorly perfused tumors. Furthermore, for a 
tumor with an irregular shape, inadequate MNPs distribution may cause under-dosage of 
heating in the tumor or overheating of the normal tissue. The second approach, is to directly 
inject MNPs into the extracellular space in the tumors. The MNPs diffuse inside the tissue 
after injection of nanofluid. If the tumor has an irregular shape, multi-site injection can be 
exploited to cover the entire target region [Salloum et al. (2008a)]. 
The nanofluid injection volume as well as infusion flow rate of nanofluid are important 
factors in dispersion and concentration of the MNPs, within the tissue. A successful MFH 
treatment is substantially dependent on the MNPs distribution in the tissue [Bagaria and 
Johnson (2005), Salloum et al. (2008a), Salloum et al. (2008b), Lin and Liu (2009), Bellizzi and 
Bucci (2010), Golneshan and Lahonian (2011a)]. 
2. Heat dissipation of MNPs 
In MFH, after introducing the MNPs into the tumor (Figure 1), an alternating magnetic field 
is applied. This causes an increase in the tumor temperature and subsequent tumor 
regression. The temperature that can be achieved in the tissue strongly depends on the 
properties of the magnetic material used, the frequency and the strength of the applied 
magnetic field, duration of application of the magnetic field, and dispersion of the MNPs 
within the tissue. 
2.1. Mechanisms of heat dissipation of MNPs 
To turn MNPs into heaters, they are subjected to an oscillating electromagnetic field, where 
the field’s direction changes cyclically. There are various theories which explain the reasons 
for the heating of the MNPs when subjected to an oscillating electromagnetic field 
[Brusentsova et al. (2005), Jo´zefczak and Skumiel (2007), Kim et al. (2008), Golneshan and 
Lahonian (2010), Golneshan and Lahonian (2011c)]. 
There exist at least four different mechanisms by which magnetic materials can generate 
heat in an alternating field [Nedelcu (2008)]: 
1. Generation of eddy currents in magnetic particles with size >1μ, 
2. Hysteresis losses in magnetic particles >1μ and multidomain MNPs, 
3. Relaxation losses in ‘superparamagnetic’ single-domain MNPs, 
4. Frictional losses in viscous suspensions. 
Relaxation losses in single-domain MNPs fall into two modes: rotational (Brownian) mode and 
Néel mode. The principle of heat generation due to each individual mode is shown in Figure 2. 
In the Néel mode, the magnetic moment originally locked along the crystal easy axis rotates 
away from that axis towards the external field. The Néel mechanism is analogous to the 
hysteresis loss in multi-domain MNPs whereby there is an ‘internal friction’ due to the  
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Figure 1. Schematic of magnetic fluid hyperthermia process. 
movement of the magnetic moment in an external field that results in heat generation. In the 
Brownian mode, the whole particle oscillates towards the field with the moment locked 
along the crystal axis under the effect of a thermal force against a viscous drag in a 
suspending medium. This mechanism essentially represents the mechanical friction 
component in a given suspending medium [Nedelcu (2008)]. 
 
Figure 2. Relaxation mechanisms of MNPs in Magnetic Fluid. a) Brownian relaxation, entire particle 
rotates in fluid; b) Néel relaxation, direction of magnetization rotates in core. The structure of MNP: 
core (inner), shell (outer). The arrow inside the core represents the direction of magnetization. 
Power dissipation of MNPs in an alternating magnetic field is expressed as [Rosensweig 
(2002), Nedelcu (2008)]: ܲ = ߨߤ଴ݔ଴ܪ଴ଶ݂ 2ߨ݂߬1 + (2ߨ݂߬)ଶ (1)
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where ߤ଴	(4ߨ. 10ି଻	ܶ.݉/ܣ) is the permeability of free space, ݔ଴ is the equilibrium 
susceptibility,  ܪ଴ and ݂ are the amplitude and frequency of the alternating magnetic field 
and ߬ is the effective relaxation time, given by: ߬ିଵ = ߬ேିଵ + ߬஻ିଵ (2)
where ߬ே and ߬஻ are the Néel relaxation and the Brownian relaxation time, respectively. ߬ே 
and ߬஻ are written as: ߬ே = √ߨ2 ߬଴ ݁ݔ݌(Γ)√Γ  (3)߬஻ = 3ߟ ுܸ݇ܶ  (4)
where the shorter time constant tends to dominate in determining the effective relaxation 
time for any given size of particle. ߬଴ is the average relaxation time in response to a 
thermal fluctuation, ߟ is the viscosity of medium, ுܸ is the hydrodynamic volume of 
MNPs, ݇ is the Boltzmann constant,	1.38 × 10ିଶଷ	J/K, and ܶ is the temperature. Here, 
Γ = ܭ ெܸ/	݇ܶ where ܭ is the magnetocrystalline anisotropy constant and ெܸ is the volume 
of MNPs. The MNPs volume ெܸ and the hydrodynamic volume including the ligand layer ுܸ are written as:  
ெܸ = ߨܦଷ6  (5)
ுܸ = ߨ(ܦ + 2ߜ)ଷ6  (6)
where ܦ is the diameter of MNP and	ߜ is the ligand layer thickness. 
The equilibrium susceptibility ݔ଴ is assumed to be the chord susceptibility corresponding to 
the Langevin equation (ܮ(ߦ) = ܯ ܯ௦⁄ = coth ߦ − 1 ߦ⁄ ), and expressed as: ݔ଴ = ݔ௜ 3ߦ ൬coth ߦ − 1ߦ൰ (7)
where ߦ = ߤ଴ܯௗܪ ெܸ/݇ܶ, ܪ = ܪ଴ܿ݋ݏ(߱ݐ), ܯ௦ 	= 	߶ܯௗ, and ߶ is the volume fraction of MNPs. 
Here, ܯௗ and ܯ௦ are the domain and saturation magnetization, respectively. The initial 
susceptibility is given by: 
ݔ௜ = ߤ଴߶ܯௗଶ ெܸ3݇ܶ  (8)
Generally, the practical range of frequency and amplitudes are often described as 50	– 1200	݇ܪݖ and 0– 15	݇ܣ/݉ and the typical magnetite dosage is ~10	݉݃ magnetite MNPs 
per gram of tumor as reported in clinical studies [Jordan et al. (1997), Jordan et al. (2001), 
Pankhurst et al. (2003), Lahonian and Golneshan (2011)]. 
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2.2. Heating rate of aqueous dispersions of MNPs 
Based on the theory mentioned in previous section, Lahonian and Golneshan (2011) 
calculated the power dissipations for aqueous dispersion of mono-dispersed equiatomic face 
centred cubic iron-platinum (FCC FePt) MNPs varying the diameter of MNP in adiabatic 
condition. For comparison, also the power dissipations for magnetite (Fe3O4), and 
maghemite (γ-Fe2O3 ) have been estimated. In Table 1, physical properties of each magnetic 
material are shown [Maenosono and Saita (2006)]. 
In practice, the magnetic anisotropy may considerably vary due to the shape contributions 
of MNPs. For simplicity, however, the shape effect is not taken into account in the above 
mentioned model. 
It has been pointed out that hysteresis losses are important especially for magnetic single 
domain particles with high magneto-crystalline anisotropy [Hergt et al. (1998)]. However, 
the hysteresis losses are not considered, because MNPs are assumed as super-paramagnetic 
in their study. 
Figure 3 shows comparative power dissipation for aqueous mono-dispersions of the various 
MNPs listed in Table 1, assuming ߬଴ = 10ିଽ	ݏ and ߶ = 2 × 10ିହ. Induction and frequency of 
applied magnetic field were fixed at ܤ଴ = ߤ଴ܪ଴ = 50	݉ܶ and 300	݇ܪݖ. The carrier liquid is 
pure water in all cases. Surface ligand layer thickness is assumed to be ߜ = 1	݊݉. On these 
conditions, FCC FePt MNPs yield the largest power dissipation. Most operative sizes of each 
MNPs, ܦ௠௔௫, which give a maximum heating rate, are 10.5	݊݉ for FCC FePt MNPs, 19	݊݉ 
for magnetite and 23	݊݉ for maghemite. The maghemite MNPs also have large power 
dissipation as well as magnetite MNPs. The typical size ranges of standard magnetic 
nanofluid are ܦ = 8 − 10	݊݉, and generally the stability of magnetic colloid becomes 
impaired when ܦ > 20	݊݉ due to the spontaneous magnetization [Golneshan and Lahonian 
(2010), Lahonian and Golneshan (2011), Golneshan and Lahonian (2011b). 
Figure 4 shows the dependence of power dissipation on induction of applied magnetic field, 
for fixed ݂ = 300	݇ܪݖ. Note that ܤ଴ is varied as 30, 50, and 80	݉ܶ. Increasing ܤ଴ earns a 
raise for power dissipation [Lahonian and Golneshan (2011)]. 
Figures 5, 6 and 7 show the dependence of power dissipation on the frequency (݂), the 
surface ligand layer thickness (ߜ	), and the volume fraction (߶	) respectively. Increasing ݂ 
earns a raise and a gradual decrease, respectively, in the power dissipation and ܦ௠௔௫. The 
power dissipation decreases and increases with increasing ߜ and ߶, respectivly. Also, the 
gradual decrease in ܦ௠௔௫ with decreasing ߜ is observed [Lahonian and Golneshan (2011)]. 
 
Material 
ܯௗ݇ܣ ݉⁄ ܭ ݇ܬ ݉ଷ⁄ ܿ௣ܬ (݇݃. ܭ)⁄ ߩ ݇݃ ݉ଷ⁄  
FCC FePt 1140 206 327 15200 
Magnetite 446 9 670 5180 
Maghemite 414 4.7 746 4600 
Table 1. Physical properties of various MNPs [Maenosono and Saita (2006)] 
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Figure 3. Power dissipations as a function of particle diameter for various MNPs [Lahonian and 
Golneshan (2011)]. 
 
Figure 4. Dependence of power dissipation on ܤ଴	[Lahonian and Golneshan (2011)]. 
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Figures 4 to 7 show that dispersion and concentration of MNPs inside the tissue are 
important factors in heat dissipation of MNPs and temperature distribution inside the 
tumor and its surrounding healthy tissue. Also, the effect of concentration of MNPs is 
comparable with the effects of induction and frequency of the magnetic field on the 
maximum power dissipation. Therefore, study of the MNPs diffusion and concentration, 
possesses a high degree of importance. 
 
Figure 5. Dependence of power dissipation on ݂	[Lahonian and Golneshan (2011)]. 
 
Figure 6. Dependence of power dissipation on ߜ	[Lahonian and Golneshan (2011)]. 
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Figure 7. Dependence of power dissipation on ߶	[Lahonian and Golneshan (2011)]. 
3. Diffusion of MNPs within the biological tissue 
The relationship among the MNPs distribution, the blood perfusion, the infusion flow rate, 
the injection volume of nanofluid, and the tissue structure are not well understood. It is 
difficult to devise a treatment protocol that enables the optimum distribution of temperature 
elevation in the tumor. Hence, it is important to quantify the MNPs distribution and heating 
pattern following the injection regarding the above mentioned factors [Salloum et al. 
(2008b)]. 
Diffusion in isotropic tissues, can be modeled as [Nicholson (2001)]: ߲߲ܥݐ = D∗∇ଶܥ + ܵ ߝ⁄  (9)
where ܥ, ܦ∗, ܵ, ߝ and ݐ are the volume average concentration of the species, effective 
diffusivity, mass source density, porosity of the tissue and time, respectively. The effective 
diffusivity, however, is related to the tortuosity of the tissue, ߣ, and the diffusivity in the 
absence of the porous medium, ܦ through the following relation: ܦ∗ = ܦ ߣଶ⁄ (10)
Therefore an increase in the tortuosity and a decrease in the porosity have significant effects 
on reducing the effective mass diffusivity. 
Experimental study of Salloum et al. (2008a) in a tissue-equivalent agarose gel, showed that 
the particle concentration was not uniform after the injection and were confined in the 
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vicinity of the injection site. Also the particle deposition was greatly affected by the injection 
rate and amount. Furthermore, the shape of the distribution tended to be more irregular 
with higher infusion flow rate. 
Due to difficulties in experimental studies, to understand the actual spatial distribution of 
the MNPs after being injected into the tumor, some numerical simulations have been down. 
Diffusion of MNPs inside the tissue was simulated by Golneshan and Lahonian (2011a). A 
square region with side of 2	ܿ݉ was chosen as the domain of the analysis (Figure 8). Water-
based ferrofluid with a concentration of 3.3% by volume and a particle size of 10	݊݉ 
magnetite MNPs was used in their work. Based on the density of magnetite (5240 ݇݃ ݉ଷ⁄ ) 
and the given ferrofluid concentration, each 0.1	ܿܿ of ferrofluid contains 17.3݉݃ of solid iron 
oxide [Golneshan and Lahonian (2010)]. The ferrofluid infusion flow rates were chosen 
equal to ሶܸ = 10, 20 and 30	ߤ݈/݉݅݊ and ferrofluid injection volumes were chosen equal to ܸ = 0.1, 0.2 and 0.3	ܿܿ. Porosity and effective diffusivity were chosen to be equal to ߝ = 0.1 
and ܦ∗ = 2.5 × 10ିଵ଴ 	݉ଶ ݏ⁄  respectively [Nicholson (2001), Golneshan and Lahonian (2010)].  
Figure 9 shows the concentration of ferrofluid in the tissue for ܸ = 0.2	ܿܿ and ሶܸ = 20	ߤ݈/݉݅݊, 
for different time intervals after the end of ferrofluid injection. Results show that the 
concentration of ferrofluid is maximum at the injection site, and decreases rapidly with 
increasing distance from it. Also, concentration of ferrofluid decreases at the injection area 
with time and increases in the surrounding of injection site [Golneshan and Lahonian 
(2011a)]. 
 
Figure 8. Simulation domain of tissue and injection site.  
Figure 10 shows volume fraction of MNPs in the tissue for different ferrofluid injection 
volumes, ሶܸ = 20	 ߤ݈ ݉݅݊⁄ , at 20 minutes after the end of ferrofluid injection [Golneshan and 
Lahonian (2011a)].  
Figure 11 shows the concentration of ferrofluid in the tissue for ܸ = 0.2	ܿܿ, and different 
infusion flow rates, just 20 minutes after the end of ferrofluid injection. Results show that 
2 ܿ݉
2	ܿ݉	
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the increasing infusion flow rate, increases concentration of ferrofluid in the vicinity of the 
injection site while decreasing the concentration in the layers far from the injection site 
[Golneshan and Lahonian (2011a)]. 
 
Figure 9. Concentration of ferrofluid in the tissue, for different time intervals after the end of ferrofluid 
injection (ܸ = 0.2	ܿܿ and ሶܸ = 20	ߤ݈/݉݅݊) [Golneshan and Lahonian (2011a)]. 
 
Figure 10. Ferrofluid concentration for ሶܸ = 20	 ߤ݈ ݉݅݊⁄ , and different ferrofluid injection volumes, just 
20 minutes after the end of ferrofluid injection [Golneshan and Lahonian (2011a)]. 
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Figure 11. Concentration of ferrofluid in the tissue for ܸ = 0.2	ܿܿ, and different infusion flow rates, just 
20 minutes after the end of ferrofluid injection [Golneshan and Lahonian (2011a)]. 
Figure 12 shows the concentration of ferrofluid in the tissue for ܸ = 0.2	ܿܿ, and different 
infusion flow rates, just 20 minutes after the end of ferrofluid injection. Results show that 
the increasing infusion flow rate, increases concentration of ferrofluid in the vicinity of the 
injection site but decreases the concentration in the layers far from the injection site 
[Golneshan and Lahonian (2010), Golneshan and Lahonian (2011a)]. 
4. Diffusion of MNPs in a biological tissue for mono and multi-site 
injection for irregular tumors 
Golneshan and Lahonian (2011a) studied diffusion of MNPs in a biological tissue for 
irregular tumors. A 2 × 2	ܿ݉ tissue with an irregular tumor inside, was chosen as the 
domain of the analysis (Figures 13a).  
They considered multi-site injection as shown in Figure 13d and divided the irregular 
tumor almost into four equal sections. In each injection site, one fourth the amount of 0.2	ܿܿ ferrofluid was injected. Figure 14 shows the concentration of ferrofluid for infusion 
flow rate of ሶܸ = 20	 ߤ݈ ݉݅݊⁄ , at the end of ferrofluid injection [Golneshan and Lahonian 
(2011a)].  
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Figure 12. Concentration of ferrofluid in ݇݃/݉ଷ in the tissue for ܸ = 0.2	ܿܿ, ሶܸ = 20	 ߤ݈ ݉݅݊⁄ , at 20, 40 
and 60 minutes after the end of ferrofluid injection [Golneshan and Lahonian (2011a)].  
 
Figure 13. a: The tissue and an irregular tumor, b: Zoomed irregular tumor c: Mono-site injection, d: 
Multi-site injection [Golneshan and Lahonian (2011a)]. 
Figure 15 shows the concentration of ferrofluid in ݇݃ ݉ଷ⁄  in the tissue for mono and multi-
site injection of ܸ = 0.2	ܿܿ	ferrofluid injection volume and infusion flow rate of ሶܸ =20	 ߤ݈ ݉݅݊⁄ , at 10, 20, and 30	minutes after the end of ferrofluid injection. Ten minutes after  
  
 
 
0.0 0.5 1.0 1.5 2.0
0.0
0.5
1.0
1.5
2.0
0 100 200 300 400
 
 
 
 
0 100 200
 
 
 
 
50 100 150
20 minutes 40 minutes 60 minutes
2 ܿ݉
2	ܿ݉	
(a)
(b) 
(c) (d) 
 
Diffusion of Magnetic Nanoparticles Within a Biological Tissue During Magnetic Fluid Hyperthermia 141 
 
Figure 14. Concentration of ferrofluid in ݇݃ ݉ଷ⁄  for multi-site injection, at the end of injection process 
[Golneshan and Lahonian (2011a)]. 
 
Figure 15. Concentration of ferrofluid in ݇݃/݉ଷ in the tissue for ܸ = 0.2	ܿܿ, ሶܸ = 20	 ߤ݈ ݉݅݊⁄ , at 10, 20 
and 30 minutes after the end of ferrofluid injection. Up row: Mono-site injection, Down row: Multi-site 
injection [Golneshan and Lahonian (2011a)]. 
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the injection, the maximum concentration of ferrofluid happens at the injection sites, 
decreasing rapidly with increasing the distance from the injection sites. At this stage, nearly 
clear boundaries are seen between diffused ferrofluid for each injection regions. As 
ferrofluid diffuses more and more, these boundaries are disappeared. Thirty minutes after 
the injection, the ferrofluid is spread all over the tomour [Golneshan and Lahonian (2011a)]. 
Comparison between mono-site and multi-site injections in Figures 15 show that diffusion of 
ferrofluid in the tissue for a multi-site injection is much more uniform and covers all points 
inside the tumor 30 minutes after the end of injection process. Furthermore, no substantial 
concentration gradient is seen between the center and the boundary of the tumor at this time 
for the multi-site injection case [Golneshan and Lahonian (2011a)]. 
5. Conclusion 
Results showed and clarified that increasing the magnetic nanofluid injection volume, 
increases the concentration of MNPs inside the tissue. Also, increasing magnetic nanofluid 
infusion flow rate increased the concentration of MNPs in the center of the tumor only. For 
irregular tumors, the effect of multi-site injection was investigated. Results showed that 
multi-site injection of specific quantity of magnetic nanofluid provided a better distribution 
of MNPs inside the tumor, in contrast to mono-site injection. 
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